BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26992225)

  • 1. Non‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles.
    Koppers-Lalic D; Hackenberg M; de Menezes R; Misovic B; Wachalska M; Geldof A; Zini N; de Reijke T; Wurdinger T; Vis A; van Moorselaar J; Pegtel M; Bijnsdorp I
    Oncotarget; 2016 Apr; 7(16):22566-78. PubMed ID: 26992225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
    Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
    Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity Captured Urinary Extracellular Vesicles Provide mRNA and miRNA Biomarkers for Improved Accuracy of Prostate Cancer Detection: A Pilot Study.
    Davey M; Benzina S; Savoie M; Breault G; Ghosh A; Ouellette RJ
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients.
    Ramirez-Garrastacho M; Berge V; Linē A; Llorente A
    Br J Cancer; 2022 Feb; 126(3):492-501. PubMed ID: 34811506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
    Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
    Med Oncol; 2024 Jun; 41(7):169. PubMed ID: 38839666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer.
    Bryzgunova OE; Zaporozhchenko IA; Lekchnov EA; Amelina EV; Konoshenko MY; Yarmoschuk SV; Pashkovskaya OA; Zheravin AA; Pak SV; Rykova EY; Laktionov PP
    PLoS One; 2019; 14(4):e0215003. PubMed ID: 30970027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of urine-circulating miRNAs for detection of prostate cancer.
    Stuopelyte K; Daniunaite K; Bakavicius A; Lazutka JR; Jankevicius F; Jarmalaite S
    Br J Cancer; 2016 Sep; 115(6):707-15. PubMed ID: 27490805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
    Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L; Ferrer F; Serra M; Arévalo A; Gavagnach M; Giménez N; Filella X
    Prostate; 2017 May; 77(6):573-583. PubMed ID: 27990656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors.
    Strømme O; Heck KA; Brede G; Lindholm HT; Otterlei M; Arum CJ
    Curr Issues Mol Biol; 2021 Jun; 43(1):286-300. PubMed ID: 34199766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214.
    Srivastava A; Goldberger H; Dimtchev A; Ramalinga M; Chijioke J; Marian C; Oermann EK; Uhm S; Kim JS; Chen LN; Li X; Berry DL; Kallakury BV; Chauhan SC; Collins SP; Suy S; Kumar D
    PLoS One; 2013; 8(10):e76994. PubMed ID: 24167554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
    Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Extracellular Vesicle miRNAs Can Identify Lung Cancer, Current Smoking Status, and Stable COPD.
    O'Farrell HE; Bowman RV; Fong KM; Yang IA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (
    Fredsøe J; Rasmussen AKI; Laursen EB; Cai Y; Howard KA; Pedersen BG; Borre M; Mouritzen P; Ørntoft T; Sørensen KD
    Clin Chem; 2019 Apr; 65(4):540-548. PubMed ID: 30728149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary microRNAs expression in prostate cancer diagnosis: a systematic review.
    Paiva RM; Zauli DAG; Neto BS; Brum IS
    Clin Transl Oncol; 2020 Nov; 22(11):2061-2073. PubMed ID: 32323148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
    Korzeniewski N; Tosev G; Pahernik S; Hadaschik B; Hohenfellner M; Duensing S
    Urol Oncol; 2015 Jan; 33(1):16.e17-16.e22. PubMed ID: 25445383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
    Ozawa PMM; Vieira E; Lemos DS; Souza ILM; Zanata SM; Pankievicz VC; Tuleski TR; Souza EM; Wowk PF; Urban CA; Kuroda F; Lima RS; Almeida RC; Gradia DF; Cavalli IJ; Cavalli LR; Malheiros D; Ribeiro EMSF
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31963351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.